# Efficacy and safety evaluation of a combination of iguratimod and methotrexate therapy for active rheumatoid arthritis patients: a randomized controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-evaluation-of-a-combination-of-iguratimod-and-methotrexate/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xinwang Duan,Xiuling Zhang,Shao-Yuan Mao,Jingjing Shang,Xiaodong Shi |
| Citations | 38 |
| DOI | 10.1007/s10067-015-2999-6 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W765976976 |
| PMID | 26139202 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Xinwang Duan](https://scholariq.org/researchers/xinwang-duan/)

## Paper journal

- [Clinical Rheumatology](https://scholariq.org/journals/clinical-rheumatology/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Toxin Mechanisms and Immunotoxins](https://scholariq.org/topics/toxin-mechanisms-and-immunotoxins/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.